|
Pharmaceutical Applications
 Pharmaceutical manufacturing continues to push the envelope with more direct-compression blends, more potent active ingredients, wider particle size distributions, larger batches, and faster production rates. Faster time to market results in less time to optimize formulations or processes. These trends are leaving pharmaceutical operations increasingly vulnerable to process problems caused by segregation [220K QuickTime video] and poor flow. At Jenike & Johanson, our mission is to help you avoid or minimize the costly consequences of product variation caused by poor powder flow.
A single defective batch of solid dosage or powder forms can cost tens to hundreds of thousands of dollars in wasted product alone. Troubleshooting time, manpower, and paperwork can easily add tens of thousands of dollars more. Delays in FDA approval while a product variation problem is corrected can result in time-to-market revenue losses of $1 million to $100 million or more over the life of your product.
If you're currently experiencing problems with blend or content uniformity, or poor flow, Jenike & Johanson can help you eliminate them. And if you're developing a new product line, we can utilize our industry-leading technology to help you get off to a smooth start and avoid production variation headaches. Contact us to discuss how your handling system can work for your bottom line.  Some of the pharmaceutical problems we have analyzed/solutions we have provided:
Case Studies Client confidentiality prevents us from discussing most of our projects. The following case study was written with the consent of our client. Additional pharmaceutical case studies are currently being prepared for posting to this site. Please visit us again.
Some of the pharmaceutical materials we have handled:
A partial listing of our pharmaceutical clients:
|
|||||||||||||
|
||||||||||||||
|
||||||||||||||
 |
Even once validated, USP guidelines won't guarantee that every individual dose produced will be acceptable. More difficulties may be in store if a defective product reaches the marketplace. With insufficient active ingredient, the product will lack potency; with too much active ingedient, the product will cause side effects. Either way, dissatisfied customers mean lower sales and a poor company image—to say nothing of the health risks involved. 
Some of the pharmaceutical equipment we have designed and supplied:
